NTRK3 has been associated with tumor mutation burden and immune infiltration in bladder cancer [36] and with TLSs and TILs in gastrointestinal stromal tumors (GISTs) [37]. This evidence concerns the gene NTRK3 and urinary bladder carcinoma.